Responding to the challenge of recruiting for orphan diseases

Over the last few decades I have witnessed profound changes and advances not only in the range of treatments but in the way, and now the variety of venues used to administer drugs for clinical trials. This diversity in administration has brought with it some interesting challenges for both the recipients […]

Read More